A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

 Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.

 

To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

 

The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments:

·       Type of Modular Construct 

§  Hybrid Skid

§  Plug-and-Play

§  Skid-Mounted

§  Truckable

§  Others

§  Type of Construction Component

§  Base Building

§  Electrical System

§  Mechanical System

§  Process Equipment

§  Process Piping

§  Process Utilities

§  Other Components

§  Purpose of Facility

§  Aseptic Filling

§  Manufacturing

§  Research and Development

§  Others

§  Facility Area

§  Very Small

§  Small

§  Mid-Sized

§  Large

§  Very Large

§  Scale of Operation

§  Clinical

§  Commercial

§  Type of Industry

§  Pharmaceutical                  

§  Biotechnology

§  Type of Product

§  Biosimilars             

§  Cell and Gene Therapies

§  Monoclonal Antibodies

§  Vaccines

§  Other Products

§  Type of Facility

§  New Facility

§  Facility Expansions

§  Key Geographical Regions

§  North America                    

§  Europe

§  Asia

§  Middle East and North Africa

§  Latin America

§  Rest of the World

 

To Request Sample Pages - https://www.rootsanalysis.com/reports/178/request-sample.html

 

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  Alan de Zayas (Modular Building Manufacturing and Construction Team, Avon Modular Construction)

§  François Abiven (Executive Vice-President Global Business Unit BLS and Luca Mussati Vice President, Pharma and Biotech Life Sciences, Exyte)

§  Maik Jornitz (President and Chief Executive Officer, G-CON Manufacturing)

§  Pär Almhem (President, Modwave)

§  Sulogna Roy (Ex Sales Manager, Zeton)

§  Vernon Solomon (Specialist in Modular Design for Cleanrooms and Close Tolerance Temperature and Humidity Control, Environmental Systems Corporation)

 

The Modular Facilities in Pharmaceutical and Biotechnology Market, 2021-2030 report features the following companies, which we identified to be key players in this domain:

§  Cytiva

§  G-CON Manufacturing

§  Pharmadule Morimatsu

§  NNE

§  IPM Technologies

§  KeyPlants

§  Germfree Laboratories

§  ModuleCO Pharma

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

 

4. Market Landscape: Modular Facility Manufacturers

5. Market Landscape: Modular Cleanroom Providers

6. Company Profiles

7. Partnerships and Collaborations

8. Feasibility Study

9. Facility Construction Trends in Pharmaceutical Industry

10. Market Forecast

11. Prevalent and Emerging Industry Trends

12. Future Growth Opportunities

13. Conclusion

14. Executive Insights

15. Appendix 1. Tabulated Data

 

16. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

 

Download Free Insights now - https://www.rootsanalysis.com/reports/178/free-insights.html

 

You may also be interested in the following titles:

1.     Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030

2.     Biopharmaceutical CROs Market, 2021-2030

3.     Continuous Manufacturing Equipment Providers Market, 2021-2030

4.     DNA-Encoded Libraries: Platforms and Services Market

5.     Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028

 

 

Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more